Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Covington
Federal Trade Commission
Colorcon
Fish and Richardson
AstraZeneca
Teva
Cerilliant
Deloitte

Generated: May 26, 2018

DrugPatentWatch Database Preview

SODIUM POLYSTYRENE SULFONATE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Sodium Polystyrene Sulfonate patents expire, and what generic alternatives are available?

Sodium Polystyrene Sulfonate is a drug marketed by Apnar Pharma Lp, Belcher Pharms Llc, Citrusphrma, Cmp Pharma Inc, Eci Pharms Llc, Epic Pharma Llc, Nuvo Pharm Inc, Wockhardt, Morton Grove, Paddock Llc, Roxane, and West-ward Pharms Int. and is included in twelve NDAs.

The generic ingredient in SODIUM POLYSTYRENE SULFONATE is sodium polystyrene sulfonate. There are one thousand four hundred and twenty-six drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the sodium polystyrene sulfonate profile page.
Drug patent expirations by year for SODIUM POLYSTYRENE SULFONATE
Synonyms for SODIUM POLYSTYRENE SULFONATE
1D1822L42I
25704-18-1
25704-18-1 (homopolymer hydrochloride salt)
28210-41-5
37286-92-3 (homopolymer calcium salt)
4-Ethenyl-benzenesulfonic acid sodium salt homopolymer
4-ethenylbenzenesulfonic acid
4-Ethenylbenzenesulfonic acid homopolymer
4-Styrenesulfonic acid
4-Styrenesulfonic acid sodium salt hydrate
4-vinylbenzenesulfonic acid
98-70-4
AC1L2PRS
AC1Q6WLC
AJ-31760
AK163114
AKOS024462356
AN-17828
Benzenesulfonic acid, 4-ethenyl-
Benzenesulfonic acid, 4-ethenyl-, homopolymer
CHEMBL1490300
CTK3G7745
DTXSID5045045
FT-0660598
I14-56058
MAGFQRLKWCCTQJ-UHFFFAOYSA-N
MCULE-9037247983
MFCD00165973
MolPort-001-786-409
OR046409
OR249203
p-Vinylbenzenesulfonic acid
Poly(4-vinylbenzenesulfonic acid)
Poly(4-vinylbenzenesulfonic acid)(30 wt. % in H2O)
Poly(sodium 4-styrenesulfonate)
Poly(sodium p-styrenesulfonate)
Poly(sodium styrenesulfonate)
poly(sodium-p-styrenesulfonate)
poly(styrene sulfonic acid) sodium salt
Poly(styrene sulfonic acid) sodium salt, MW ~ 70,000 50g
Poly(styrene sulfonic acid), M.W. 75,000, 30% w/v aqueous solution
Polystyrene sulfonate
Polystyrene sulfonic acid
Polystyrene sulfonic acid (rigid, macroporous 200-400 micrometer, 1-2 mmol/g)
SC-73417
SCHEMBL25711
Sodium polystyrene sulfonic acid
ST50825215
styrene-4-sulphonic acid
Tolevamer [INN]
UNII-1D1822L42I
UNII-UHW48O2R88 component MAGFQRLKWCCTQJ-UHFFFAOYSA-N
ZINC1841096

US Patents and Regulatory Information for SODIUM POLYSTYRENE SULFONATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apnar Pharma Lp SODIUM POLYSTYRENE SULFONATE sodium polystyrene sulfonate POWDER;ORAL, RECTAL 206815-001 Feb 18, 2016 AA RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Nuvo Pharm Inc SODIUM POLYSTYRENE SULFONATE sodium polystyrene sulfonate POWDER;ORAL, RECTAL 204071-002 Nov 28, 2014 RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Cmp Pharma Inc SODIUM POLYSTYRENE SULFONATE sodium polystyrene sulfonate POWDER;ORAL, RECTAL 089910-001 Jan 19, 1989 AA RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Roxane SODIUM POLYSTYRENE SULFONATE sodium polystyrene sulfonate SUSPENSION;ORAL, RECTAL 088453-001 Nov 17, 1983 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Argus Health
Mallinckrodt
Cerilliant
Farmers Insurance
Cantor Fitzgerald
QuintilesIMS
Julphar
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.